Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 2 | 140↑9109.6% | 0 | 0 | 24 |
| Gross Profit | 2 | 140↑9109.6% | 0 | 0 | 23 |
| Operating Income | -71 | 26↑136.7% | -152↓678.8% | -230↓51.5% | -340↓47.7% |
| Net Income | -73 | 25↑134.1% | -149↓699.1% | -209↓40.2% | -319↓52.3% |
| EBITDA | -70 | 27↑138.2% | -146↓644.0% | -209↓43.1% | -314↓50.1% |
| EPS Diluted | -1.77 | 0.48↑127.1% | -2.46↓612.5% | -2.98↓21.1% | -3.73↓25.2% |